Loss of Expression and Altered Localization of KAI1 and CD9 Protein Are Associated with Epithelial Ovarian Cancer Progression

Author： Houle C.D.   Ding X-Y.   Foley J.F.   Afshari C.A.   Barrett J.C.   Davis B.J.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.86, Iss.1, 2002-07, pp. : 69-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Downregulation of KAI1 Metastasis Suppressor Protein Is Associated with a Dismal Prognosis in Epithelial Ovarian Cancer

By Schindl M.   Birner P.   Breitenecker G.   Oberhuber G.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 244-248

Elsevier

Access to resources Recommend Favorite

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

By Chen Hongmin   Wang Li   Beretov Julia   Hao Jingli   Xiao Weiwei   Li Yong  

Clinical and Experimental Metastasis, Vol. 27, Iss. 8, 2010-12 ,pp. : 557-569

Springer Publishing Company

Access to resources Recommend Favorite

Role of CSF-1 in progression of epithelial ovarian cancer

By Chambers Setsuko K  

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1429-1440

Future Medicine

Access to resources Recommend Favorite

Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma

By                            

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1681-1686

Spandidos Publications

Access to resources Recommend Favorite

Expression and Subcellular Localization of the Cyclin-Dependent Kinase Inhibitor p27 Kip1 in Epithelial Ovarian Cancer

By Hurteau J.A.   Allison B.M.   Brutkiewicz S.A.   Goebl M.G.   Heilman D.K.   Bigsby R.M.   Harrington M.A.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 292-298

Elsevier

Access to resources Recommend Favorite